Ultragenyx Pharmaceu (RARE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -575,000 | -446,444 | -266,031 | -151,080 | -569,000 |
| Depreciation Amortization | 31,000 | 22,731 | 14,829 | 7,257 | 23,000 |
| Accounts receivable | -31,000 | 2,834 | -2,591 | 10,062 | -34,000 |
| Other Working Capital | -23,000 | -23,588 | -78,447 | -56,633 | 14,000 |
| Other Operating Activity | 132,000 | 78,296 | 57,492 | 23,919 | 152,000 |
| Operating Cash Flow | $-466,000 | $-366,171 | $-274,748 | $-166,475 | $-414,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 258,000 | 329,582 | 210,794 | 136,994 | 4,000 |
| PPE Investments | -6,000 | -5,062 | -3,784 | -1,324 | -7,000 |
| Sale Of Investment | N/A | N/A | 143 | N/A | N/A |
| Purchase Sale Intangibles | -15,000 | -15,000 | -15,000 | -15,000 | -13,000 |
| Other Investing Activity | -16,000 | -16,273 | -16,088 | -15,780 | -15,000 |
| Investing Cash Flow | $236,000 | $308,247 | $191,065 | $119,890 | $-18,000 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 86,000 | 83,808 | 83,806 | 157 | 399,000 |
| Other Financing Activity | 392,000 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $478,000 | $83,808 | $83,806 | $157 | $399,000 |
| Exchange Rate Effect | 4,000 | 4,656 | 4,362 | 1,448 | -2,000 |
| Beginning Cash Position | 184,000 | 184,159 | 184,159 | 184,159 | 219,000 |
| End Cash Position | 436,000 | 214,699 | 188,644 | 139,179 | 184,000 |
| Net Cash Flow | $252,000 | $30,540 | $4,485 | $-44,980 | $-35,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | -466,000 | -366,171 | -274,748 | -166,475 | -414,000 |
| Capital Expenditure | -6,000 | -5,062 | -3,784 | -1,324 | -7,000 |
| Free Cash Flow | -472,000 | -371,233 | -278,532 | -167,799 | -421,000 |